Skip to main content

Biotech firm with Bham operations raises $10M in funding

The company funding is to further push its products to market, starting with a Phase 1 in Q1 2019.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.